Table 8.
HADS-A: 8–10 |
HADS-A ≥11 |
|||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
History of treatment discontinuation | inf | inf | 0.971 | 1.03 | 0.06–17.30 | 0.981 |
5-aminosalicylic acid | 1.22 | 0.25–5.84 | 0.807 | 0.35 | 0.06–1.91 | 0.224 |
Steroid | 17.03 | 2.24–129.20 | 0.006* | 9.82 | 0.55–174.14 | 0.119 |
Anti-TNF-α | 0.42 | 0.15–1.23 | 0.113 | 0.61 | 0.12–3.15 | 0.559 |
Multivariable analysis was performed after selecting variables with p<0.1 from univariate logistic regression analysis.
p<0.05, the references for comparative analysis were 0-7 for HADS-A.
CD: Crohn’s disease, HADS: Hospital and Anxiety Depression Scale, anti-TNF-α: anti-tumor necrosis factor-alpha, OR: odds ratio, CI: confidence interval, inf: infinite